Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Globus Medical Inc Reaffirms FY 2013 Guidance


Thursday, 1 Aug 2013 04:10pm EDT 

Globus Medical Inc reiterated its revenue outlook and non-GAAP diluted earnings per share guidance for fiscal 2013. For 2013, the Company continues to expect full-year revenue to be approximately $432 million and non-GAAP annual diluted earnings per share, which excludes provisions for litigation losses, to be approximately $0.81. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $434 million and EPS of $0.83 for fiscal 2013. 

Company Quote

24.2
-0.31 -1.26%
19 Dec 2014